KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Assets: 2010-2025

Historic Return on Assets for Ionis Pharmaceuticals (IONS) over the last 15 years, with Sep 2025 value amounting to -0.09%.

  • Ionis Pharmaceuticals' Return on Assets rose 4.00% to -0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.09%, marking a year-over-year increase of 4.00%. This contributed to the annual value of -0.15% for FY2024, which is 2.00% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Return on Assets of -0.09% as of Q3 2025, which was up 7.91% from -0.09% recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Return on Assets high stood at 0.00% for Q3 2022, and its period low was -0.25% during Q3 2021.
  • For the 3-year period, Ionis Pharmaceuticals' Return on Assets averaged around -0.12%, with its median value being -0.12% (2024).
  • In the last 5 years, Ionis Pharmaceuticals' Return on Assets declined by 28bps in 2021 and then rose by 25bps in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' Return on Assets (Quarterly) stood at -0.01% in 2021, then declined by 10bps to -0.11% in 2022, then fell by 1bps to -0.12% in 2023, then dropped by 3bps to -0.15% in 2024, then climbed by 4bps to -0.09% in 2025.
  • Its last three reported values are -0.09% in Q3 2025, -0.09% for Q2 2025, and -0.16% during Q1 2025.